Issued Patents All Time
Showing 1–17 of 17 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12233065 | Inhibitors of RNA helicase DHX9 and uses thereof | Kenneth W. Duncan, Brian Andrew Sparling, Andrew Tasker, Gavin Alistair Whitlock | 2025-02-25 |
| 12162867 | Inhibitors of RNA helicase DHX9 and uses thereof | Kenneth W. Duncan, Brian Andrew Sparling, Andrew Tasker, Gavin Alistair Whitlock | 2024-12-10 |
| 11623930 | Imidazodiazepinediones and methods of use thereof | Maolin Yu, Jean-Christophe Harmange, Thomas T. Tibbitts, Mark Ledeboer, Neil A. Castle +1 more | 2023-04-11 |
| 11046690 | Pyridazinones and methods of use thereof | Mark Ledeboer, Maolin Yu, Jean-Christophe Harmange | 2021-06-29 |
| 10745364 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more | 2020-08-18 |
| 10654850 | Pyridazinones and methods of use thereof | Mark Ledeboer, Maolin Yu, Jean-Christophe Harmange | 2020-05-19 |
| 10221146 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more | 2019-03-05 |
| 9809561 | Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen +9 more | 2017-11-07 |
| 9783511 | Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +6 more | 2017-10-10 |
| 9663502 | 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease | Thomas D. Aicher, Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more | 2017-05-30 |
| 9663522 | 3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof | Kenneth J. Barr, John MacLean, Hongjun Zhang, Richard Thomas Beresis, Neville J. Anthony +2 more | 2017-05-30 |
| 9233979 | Compounds that are ERK inhibitors | Kevin J. Wilson, David J. Witter, Phieng Siliphaivanh, Kathryn Lipford, David L. Sloman +18 more | 2016-01-12 |
| 9227971 | Pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors | M. Arshad Siddiqui, Yang Nan, Mehul Patel, Panduranga Adulla P. Reddy, Umar Faruk Mansoor +12 more | 2016-01-05 |
| 9226922 | Compounds that are ERK inhibitors | Kevin J. Wilson, David J. Witter, Angie R. Angeles, Phieng Siliphaivanh, David L. Sloman +16 more | 2016-01-05 |
| 9023865 | Compounds that are ERK inhibitors | Jongwon Lim, Elizabeth H. Kelley, Joey L. Methot, Hua Zhou, Alessia Petrocchi +17 more | 2015-05-05 |
| 8999957 | Heterocyclic compounds as ERK inhibitors | Yongqi Deng, Liang Zhu, Gerald W. Shipps, Jr., Sie-Mun Lo, Binyuan Sun +16 more | 2015-04-07 |
| 8609897 | Trifluoromethylsulfonamide gamma secretase inhibitor | Jed Hubbs, Thomas Miller | 2013-12-17 |